Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome, i.e., having both asthma and COPD at the same time, are both chronic diseases that can be effectively controlled, but generally not cured, through active treatment.
The onset of asthma is related to genetic and environmental factors, and most patients are allergic. With the use of dry powder inhalers such as budesonide/formoterol, combined with anti-allergic drugs such as loratadine. After long-term standardized treatment and chronic disease management, more than 80% of patients can effectively control the clinical exacerbation of asthma, but generally cannot be cured.
The exact etiology of chronic obstructive pulmonary disease (COPD) is unclear, and is also the result of a combination of internal and external factors. Patients with COPD usually smoke for a long time or have a history of occupational exposure to dust and chemical gases.
COPD is also a common chronic respiratory disease that requires long-term treatment and management. Inhalation of tiotropium bromide and budesonide/formoterol is taken in the stable phase, and antibiotics such as ceftriaxone and penicillin can be used in the acute phase, with oxygen administration if necessary.
The prognosis of chronic obstructive pulmonary disease varies from person to person. If the treatment is not standardized, many of them have recurrent exacerbations or acute exacerbations, which ultimately lead to severe lung infections, pulmonary heart failure, respiratory failure, etc., and the prognosis is poor.